A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy

Clinical trial NCT07096843 · RECRUITING

Trial details

NCT number: NCT07096843
Sponsor: Climb Bio, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Membranous Nephropathy

Start date: 2025-08-25
Primary completion: 2027-10-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.